Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe

Glenmark Specialty, a Switzerland-based unit of the company, has entered into an exclusive licensing agreement with the Menarini Group for Ryaltris, the Mumbai-based drug firm said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3pacrJE
via IFTTT